Article
Cost-Effectiveness Analysis of Ezetimibe as the Add-on Treatment to Moderate-Dose…
Drug Design, Development and Therapy · 2020 · Yang H, Li N, Zhou Y, Xiao Z, Tian H, Hu M, Li S
Key facts
| Title | Cost-Effectiveness Analysis of Ezetimibe as the Add-on Treatment to Moderate-Dose Rosuvastatin versus High-Dose Rosuvastatin in the Secondary Prevention of Cardiovascular Diseases in China: A Markov Model Analysis |
|---|---|
| First author | Yang H, Li N, Zhou Y, Xiao Z, Tian H, Hu M, Li S |
| Journal | Drug Design, Development and Therapy |
| Published | Jan 14, 2020 |
| DOI | 10.2147/DDDT.S213968 |
| Devices mentioned | 201506 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1